Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03718364
Other study ID # 2018-00226; me18Kuehne2
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2010
Est. completion date December 2035

Study information

Verified date January 2024
Source University Hospital, Basel, Switzerland
Contact Michael Kuehne, MD
Phone +41 61 328 74 71
Email michael.kuehne@usb.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).


Recruitment information / eligibility

Status Recruiting
Enrollment 3000
Est. completion date December 2035
Est. primary completion date December 2035
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: - Patients not able or willing to participate in this study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Locations

Country Name City State
Switzerland Cardiology/Electrophysiology, University Hospital Basel Basel
Switzerland University Hospital Bern Bern

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillation Blood samples (biobanking) for determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation). Decisions about future analyses to be performed from stored samples will be based exclusively on scientific reasons. Blood samples gained during catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Primary changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation) changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation) before catheter-based ablation of atrial fibrillation and 3, 6 and 12 months after catheter-based ablation of atrial fibrillation
Secondary morphologic changes of left cardiac atrium echocardiography of left cardiac atrium before catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Secondary changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation) changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation) 12 months after catheter-based ablation of atrial fibrillation and then at intervals of one year until 2035